Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Go back to Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
(NASDAQ: AVIR) Delayed: 5.43 --0 (-0%)
Previous Close $5.43    52 Week High $2.00 
Open $5.43    52 Week Low $1.15 
Day High $5.43    P/E N/A 
Day Low $5.43    EPS $0.00 
Volume